CpG-ODN enhances sensitivity to chemotherapy in lung cancer cell line A549

Kai-ling WANG,Guang-ru FEI,Tao REN
DOI: https://doi.org/10.16118/j.1008-0392.2017.03.003
2017-01-01
Abstract:Objective To investigate the effect of TLR9 activator CpG-ODN on chemosensitivity of lung cancer A549 cells.Methods Cultured lung cancer A549 cells were divided into control group, DDP group, CpG-ODN group, DDP+CpG-ODN group, CpG-ODN+DDP group.Cell proliferation was analyzed with CCK-8 method;cell apoptosis was examined with flow cytometry;the mRNA expression of TLR9 was detected with RT-PCR;and the protein expression of MyD88 and AP-1 was detected with Western blotting.Results The cell proliferation was improved in CpG-ODN groups( P <0.05);there was no significant difference between CpG-ODN and CpG-ODN+DDP groups( P >0.05).The apoptosis rate of CpG-ODN+DDP was lower than that of DDP( P <0.05), and the apoptotic rate of DDP+CpG-ODN was significantly higher than that of DDP( P <0.05).The expression of TLR9 mRNA in DDP+CpG-ODN was higher than that in DDP group( P <0.05).The expression of AP-1 in DDP+CpG group was up-regulated( P <0.05).Conclusion The data indicate that the CpG-ODN can increase cell apoptosis and enhance the sensitivity of lung cancer cells to cisplatin chemotherapy.
What problem does this paper attempt to address?